MPM closes $550m fourth fund
The US-German investment house’s latest life sciences-focused fund will invest principally in US biotechnology companies.
3 January 2013•2 mins read
The US-German investment house’s latest life sciences-focused fund will invest principally in US biotechnology companies.
The largest funds take a growing share of total PE fundraising
18 hours ago · 2 mins read
Side Letter: Mid-alignment
19 hours ago · 3 mins read
Side Letter: Software stress
28 October 2026 · 3 mins read
Ardian bets on the ‘power of live’ in latest buyout fund
28 October 2026 · 3 mins read
Advent’s $27bn flagship: How it stacks up against PE’s biggest funds
27 October 2026 · 2 mins read
Apax eyes March 2027 first close for Fund XII
27 October 2026 · 2 mins read
Side Letter: Roads less traveled
27 October 2026 · 5 mins read
